Janux Therapeutics, Inc. (JANX)
15.06
+0.02
(+0.13%)
USD |
NASDAQ |
Apr 16, 15:14
Janux Therapeutics Cash from Investing (TTM) : -300.98M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Bristol Myers Squibb Co. | -4.132B |
| EyePoint Plc | 68.58M |
| CorMedix, Inc. | -308.43M |
| ADMA Biologics, Inc. | -21.89M |
| Viking Therapeutics, Inc. | 341.39M |